BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cellegy Pharmaceuticals (CLGY) To Hold Conference Call: Sale Of Assets To ProStrakan Group September 27, 2006, 12:00 Noon


9/27/2006 11:46:28 AM

HUNTINGDON VALLEY, Pa., Sept. 27 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. Richard C. Williams, Cellegy's Chairman and Interim CEO, is scheduled to speak on Wednesday, September 27, 2006 at 12:00 p.m. (Eastern).

To participate in the live conference, dial in information is as follows: Domestic US Dial In: 800-706-7749 International Dial In: 617-614-3474 Participant Pass Code: 10479330

To replay a recording of the conference after 2:00 p.m., September 27, 2006 up to ten days subsequent to the live conference, dial in information is as follows:

Domestic US Dial In: 888-286-8010 International Dial In: 617-801-6888 Participant Pass Code: 90368159 To participate in the Weblink live conference: http://phx.corporate-ir.net/playerlink.zhtml?c=99350&s=wm&e=1393665 About Cellegy

Cellegy Pharmaceuticals is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women's health care conditions, including sexual dysfunction, HIV prevention; and, gastrointestinal disorders. Savvy(R) (C31G vaginal gel), a novel microbicide gel product for contraception and the reduction in transmission of HIV in women, is currently undergoing Phase 3 clinical studies in the United States.

About ProStrakan

ProStrakan Group plc is an international specialty pharmaceutical company engaged in the research, development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets.

Cellegy Pharmaceuticals, Inc.

CONTACT: Richard C. Williams, Chairman and Interim CEO, +1-650-616-2200,or Robert J. Caso, Vice President, Finance & CFO, +1-215-914-0900, ext.603, for Cellegy Pharmaceuticals, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES